About Deep Lens
Deep Lens is a Healthcare company based in Columbus (United States) founded in 2017 by Dave Billiter and Simon Arkell, and was acquired by Paradigm in January 2023. AI and cloud-based digital pathology platform is developed. Deep Lens has raised $17.2 million across 2 funding rounds from investors including Paradigm Health, Rev1 Ventures and Sierra Ventures. Its chief executive, as recorded, is Dave Billiter. Deep Lens offers products and services including Intelligent Research Platform and Trial Management Services. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Clinical Trials. Its competitors include Inteliquet, EmergingMed and Wild Type Advocates; 2 of its 3 listed competitors have raised funding.
Company details
AI and cloud-based digital pathology platform. Their platform offers services like AI-based image detection, and workflow support, telepathology, collaboration, cloud storage, and more. The platform has APIs that are built-in for integration by hardware and software vendors and biopharma companies. The platform offers CAPCLIA imaging lab services that help pathologists for building training sets, archiving cases, and bring digital transformation.
- Headquarters Columbus, United States
- Founders Dave Billiter, Simon Arkell
- Stage Acquired
- SectorsHealthcare
- Website deeplens.ai
- Social LinkedIn X Facebook
- Acquired by Paradigm (Jan 2023)
- Total Equity Funding$17.2M (USD)
in 2 rounds
- Latest Funding Round$14M (USD), Series A
Apr 2019
- InvestorsParadigm Health
& 4 more
- Acquired byParadigm
(Jan 2023)
Products & Services of Deep Lens
Deep Lens offers a comprehensive portfolio of products and services, including Intelligent Research Platform and Trial Management Services.
Platform that connects stakeholders to streamline clinical trials and improve outcomes.
Services integrating technology for efficient drug development and enrollment processes.
Funding Insights of Deep Lens
Deep Lens has successfully raised a total of $17.2M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $14 million completed in April 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $17.2M
- Total Rounds 2
- Last Round Series A — $14M
- First Round $3.2M
(Oct 2018)
- Investors Count 4
All 2 funding rounds of Deep Lens with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2019 | $14M | Series A | – | Northpond Ventures | |
| Oct 2018 | $3.2M | Seed | – | Sierra Ventures |
5 investors in total: 5 institutional.
Investors in Deep Lens
Deep Lens has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include Paradigm Health, Rev1 Ventures and Sierra Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Startup Studio building companies in the US & Europe and Angel Network for Ohio based companies | rev1ventures.com | Columbus, United States | ||
Early-stage venture capital investments in AI, healthcare, and enterprise technologies. | sierraventures.com | |||
Venture capital is provided to B2B healthcare innovators by Tamarind Hill. | tamarind-hill.com | Dublin, United States | ||
Venture capital firm investing in life sciences & tech sectors | npv.vc | Cambridge, United States | ||
Clinical research healthcare services are provided by Paradigm. | 2003 | paradigm.inc | New York, United States |
Investor details for Deep Lens
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Deep Lens
20 people are tracked at Deep Lens (14 in leadership, 6 in team).
| Name | Role | Group |
|---|---|---|
Dave Billiter | Co-Founder & CEO | Leadership |
Simon Arkell | Co-Founder | Leadership |
Michelle Lee | Chief Operating Officer | Leadership |
Harry Hayashi | Head Of Implementation | Leadership |
Kent Thoelke | Chief Executive Officer | Leadership |
Elijah Meerson | CTO | Leadership |
Jay Trepanier | Chief Financial Officer | Leadership |
Mark Beckmeyer | Chief Information Security Officer | Leadership |
John Keyes | Vp, Engineering | Leadership |
Deb Rork | Vice President Operations | Leadership |
Kelly Haenlein | Vp, Commercial Business | Leadership |
Jonathan Hirsch | Chief Strategy and Growth Officer | Leadership |
Filiz Muharrem Seimer, MBA, CCRP | Director Clinical Operations | Leadership |
Neel Rane | Head Of Legal | Leadership |
Heather Webb | Clinical Research Lead | Team |
Trista Weber BS, CTR, RT (R) (RT) (CT) | Oncology Data Abstractor | Team |
Christine Personett | Clinical Informaticist | Team |
Corey Sebens | Provider Implementation Lead | Team |
Todd Mayover | Consultant - Virtual Privacy Officer | Team |
Kathy Tirey | Clinical Nurse | Team |
Complete people profiles for Deep Lens
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Deep Lens
4 dated milestones of Deep Lens across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Deep Lens is founded.
- Funding First funding round of $3.2M.
- Funding Latest funding round, Series A, of $14.0M.
- Exit Acquired by Paradigm.
Competitors of Deep Lens
Deep Lens has 3 listed competitors in our database, 2 of them funded. They include Inteliquet, EmergingMed and Wild Type Advocates.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| inteliquet.com | 2010 | Dover, United States | $14.6M | Clinical trial management and analytics services for pharmaceuticals are provided. | ||
| emergingmed.com | 2000 | Durham, United States | $3M | Cloud based platform to match patients with clinical trials. | ||
| wildtypeadvocates.com | 2022 | United States | Wild Type Advocates provides AI-based medical information and comprehensive solutions for oncology care. |
Detailed competitors of Deep Lens
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Deep Lens (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Deep Lens
Complete news archive for Deep Lens
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Deep Lens
Deep Lens was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Deep Lens is headquartered in Columbus, United States. It is registered at Columbus, Ohio, United States.
Dave Billiter is the CEO of Deep Lens, as recorded in our data. They have also founded this company.
Deep Lens is a funded company, having raised a total of $17.2M across 2 funding rounds to date. The company's 1st funding round was a Seed of $3.2M, raised on Oct 2018.
AI and cloud-based digital pathology platform. Their platform offers services like AI-based image detection, and workflow support, telepathology, collaboration, cloud storage, and more. The platform has APIs that are built-in for integration by hardware and software vendors and biopharma companies. The platform offers CAPCLIA imaging lab services that help pathologists for building training sets, archiving cases, and bring digital transformation.
Deep Lens's top competitors include Inteliquet, EmergingMed and Wild Type Advocates.
Deep Lens offers Intelligent Research Platform and Trial Management Services.
Deep Lens has 5 investors. Key investors include Paradigm Health, Rev1 Ventures, Sierra Ventures, Tamarind Hill, and Northpond Ventures.
Yes. Deep Lens was acquired by Paradigm in January 2023.